4.56
price down icon4.40%   -0.21
 
loading
Schlusskurs vom Vortag:
$4.77
Offen:
$4.78
24-Stunden-Volumen:
67,432
Relative Volume:
0.26
Marktkapitalisierung:
$42,688
Einnahmen:
-
Nettoeinkommen (Verlust:
$-53.12M
KGV:
-0.0419
EPS:
-108.8
Netto-Cashflow:
$-15.86M
1W Leistung:
+10.68%
1M Leistung:
-31.22%
6M Leistung:
-91.48%
1J Leistung:
-99.15%
1-Tages-Spanne:
Value
$4.51
$4.85
1-Wochen-Bereich:
Value
$4.02
$5.10
52-Wochen-Spanne:
Value
$3.82
$1,190.00

Onconetix Inc Stock (ONCO) Company Profile

Name
Firmenname
Onconetix Inc
Name
Telefon
513-620-4101
Name
Adresse
201 E. FIFTH STREET, CINCINNATI
Name
Mitarbeiter
5
Name
Twitter
Name
Nächster Verdiensttermin
2024-05-30
Name
Neueste SEC-Einreichungen
Name
ONCO's Discussions on Twitter

Vergleichen Sie ONCO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ONCO
Onconetix Inc
4.5587 42,688 0 -53.12M -15.86M -108.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.34 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.02 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
555.31 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
246.33 28.51B 3.81B -644.79M -669.77M -6.24

Onconetix Inc Aktie (ONCO) Neueste Nachrichten

pulisher
Jun 16, 2025

Onconetix Secures Nasdaq Listing with Panel Decision - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Onconetix receives positive decision by Nasdaq Hearings Panel - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Onconetix regains Nasdaq compliance after filing Q1 report - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

Onconetix, Inc. Announces Positive Decision By Nasdaq Hearings Panel - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

Onconetix Avoids Nasdaq Delisting: Key Panel Decision Keeps Biotech Stock Listed - Stock Titan

Jun 16, 2025
pulisher
Jun 12, 2025

Onconetix, Inc. SEC 10-Q Report - TradingView

Jun 12, 2025
pulisher
Jun 11, 2025

Onconetix to implement 1-for-85 reverse stock split effective June 13 By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Onconetix Issues Promissory Note to Keystone Capital - TipRanks

Jun 11, 2025
pulisher
Jun 11, 2025

Onconetix to implement 1-for-85 reverse stock split effective June 13 - Investing.com Nigeria

Jun 11, 2025
pulisher
Jun 11, 2025

Onconetix Announces 1-For-85 Reverse Stock Split - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Onconetix to Implement 1-for-85 Reverse Stock Split - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Onconetix announces 1-for-85 reverse stock split - MSN

Jun 11, 2025
pulisher
Jun 11, 2025

Onconetix, Inc. Announces Approval of 1-for-85 Reverse Stock Split by Stockholders - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Spotify Stock Soars 124% in a Year: Time to Buy, Hold or Fold? - The Globe and Mail

Jun 11, 2025
pulisher
Jun 11, 2025

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of ... - Bluefield Daily Telegraph

Jun 11, 2025
pulisher
Jun 11, 2025

Onconetix Implements Massive 1:85 Reverse Split, Slashing Shares from 44M to 521K to Save Nasdaq Listing - Stock Titan

Jun 11, 2025
pulisher
Jun 06, 2025

1 Monster Growth Stock That's Crushing the Market in 2025 - The Globe and Mail

Jun 06, 2025
pulisher
Jun 05, 2025

Onconetix Stockholders Approve Reverse Stock Split Proposal - TipRanks

Jun 05, 2025
pulisher
Jun 04, 2025

1 ETF to Buy Hand Over Fist to Follow the TACO Trade - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

Tariffs Aren't O'Reilly's Biggest Problem, This Is - The Globe and Mail

Jun 04, 2025
pulisher
Jun 02, 2025

Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Onconetix, Inc. SEC 10-K Report - TradingView

Jun 02, 2025
pulisher
May 28, 2025

Leading Industrial Manufacturer Selects HawkSearch to Power Digital Commerce Growth - The Globe and Mail

May 28, 2025
pulisher
May 23, 2025

Onconetix receives additional delisting notice from Nasdaq - Yahoo Finance

May 23, 2025
pulisher
May 23, 2025

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq - The Manila Times

May 23, 2025
pulisher
May 22, 2025

Onconetix faces potential Nasdaq delisting over filing delays By Investing.com - Investing.com Nigeria

May 22, 2025
pulisher
May 22, 2025

Onconetix receives additional notice from Nasdaq - MSN

May 22, 2025
pulisher
May 22, 2025

Onconetix Faces Nasdaq Delisting Notice Amid Compliance Issues - TipRanks

May 22, 2025
pulisher
May 22, 2025

Onconetix faces potential Nasdaq delisting over filing delays - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

Onconetix, Inc. Receives Nasdaq Delisting Letter for Failure to File Quarterly Report and Maintain Minimum Bid Price Requirements - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Onconetix Faces Triple Threat: Nasdaq Delisting Risk Over Missing Filings and 10-Cent Stock Price - Stock Titan

May 22, 2025
pulisher
May 09, 2025

Noram Receives Results for CVZ-66: High of 1540 ppm Intersection of 220ft (67.1 m) Averaging 1124 ppm of Lithium - The Globe and Mail

May 09, 2025
pulisher
May 02, 2025

ONCOOnconetix Latest Stock News & Market Updates - Stock Titan

May 02, 2025
pulisher
May 02, 2025

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit - Barchart.com

May 02, 2025
pulisher
Apr 30, 2025

Critical Alert: Onconetix Hit With Second Nasdaq Delisting Notice as Deadline Looms - Stock Titan

Apr 30, 2025
pulisher
Apr 29, 2025

Onconetix Inc [ONCO] Is Currently 14.45 above its 200 Period Moving Avg: What Does This Mean? - dbtnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Onconetix Inc (ONCO) expanding its growth trajectory ahead - Sete News

Apr 29, 2025
pulisher
Apr 28, 2025

ONCO Stock on the Rise: A Promising Investment - investchronicle.com

Apr 28, 2025
pulisher
Apr 28, 2025

This morning’s top pick is Onconetix Inc (NASDAQ:ONCO) - uspostnews.com

Apr 28, 2025
pulisher
Apr 22, 2025

Take off with Onconetix Inc (ONCO): Get ready for trading - Sete News

Apr 22, 2025
pulisher
Apr 22, 2025

ONCO’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Form 424B3Prospectus [Rule 424(b)(3)] - ADVFN

Apr 22, 2025
pulisher
Apr 21, 2025

Form 8-KCurrent report - ADVFN

Apr 21, 2025
pulisher
Apr 21, 2025

Onconetix faces third delisting threat since 2022 IPOCincinnati Business Courier - The Business Journals

Apr 21, 2025
pulisher
Apr 19, 2025

Onconetix faces Nasdaq delisting over low share price By Investing.com - Investing.com India

Apr 19, 2025
pulisher
Apr 18, 2025

Onconetix faces Nasdaq delisting over low share price - Investing.com

Apr 18, 2025
pulisher
Apr 14, 2025

ONCO’s current quarter earnings: What analysts forecast? - uspostnews.com

Apr 14, 2025
pulisher
Apr 08, 2025

ONCO stock plunges to 52-week low, touches $0.06 - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

ONCO stock plunges to 52-week low, touches $0.06 By Investing.com - Investing.com South Africa

Apr 08, 2025

Finanzdaten der Onconetix Inc-Aktie (ONCO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.00
price up icon 1.52%
$36.00
price down icon 0.06%
$21.32
price down icon 0.15%
$99.07
price down icon 1.72%
$108.80
price up icon 2.21%
biotechnology ONC
$244.86
price up icon 1.07%
Kapitalisierung:     |  Volumen (24h):